Micro-Crosslinked Hyaluronic Acid Injection of Bone And Joint
Micro-crosslinked hyaluronic acid gel acts as a lubricant and shock absorber, restoring the natural viscoelastic properties of the synovial fluid. This helps to reduce friction and improve joint function, alleviating pain and improving range of motion for the patient. Additionally, the hyaluronic acid gel can stimulate the production of endogenous hyaluronic acid and other extracellular matrix components, supporting the regeneration and repair of damaged cartilage. This combination of immediate lubrication and long-term joint structure support makes micro-crosslinked hyaluronic acid injection a valuable treatment option for individuals suffering from osteoarthritis, especially in weight-bearing joints such as the knee, hip, and ankle. The micro-crosslinking process also enhances the stability and resistance of the hyaluronic acid to enzymatic degradation, allowing for prolonged efficacy within the joint environment. This translates to a longer duration of pain relief and improved joint function for the patient, potentially delaying or reducing the need for more invasive interventions, such as joint replacement surgery. Overall, micro-crosslinked hyaluronic acid injection provides a minimally invasive, biocompatible, and effective solution for the management of osteoarthritis and other degenerative joint conditions.
Shandong Runxin Biotechnology Co., Ltd. is a leading enterprise that has been deeply involved in the biomedical field for many years, integrating scientific research, production and sales.